Author Correction: Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy.

Moretti, Federico A; Giardino, Giuliana; Attenborough, Teresa C H; Gkazi, Athina Soragia; Margetts, Ben K; la Marca, Giancarlo; Fairbanks, Lynette; Crompton, Tessa; Gaspar, H Bobby.

Afiliação

Moretti FA; UCL Great Ormond Street Institute of Child Health, London, UK. fmoretti@biochem.mpg.de.
Giardino G; UCL Great Ormond Street Institute of Child Health, London, UK.
Attenborough TCH; UCL Great Ormond Street Institute of Child Health, London, UK.
Gkazi AS; UCL Great Ormond Street Institute of Child Health, London, UK.
Margetts BK; UCL Great Ormond Street Institute of Child Health, London, UK.
la Marca G; Department of Experimental and Clinical Biomedical Sciences, University of Florence and Newborn Screening, Clinical Chemistry and Pharmacology Lab, Meyer Children's Hospital, Florence, Italy.
Fairbanks L; Purine Research Laboratory, St Thomas' Hospital, London, UK.
Crompton T; UCL Great Ormond Street Institute of Child Health, London, UK.
Gaspar HB; UCL Great Ormond Street Institute of Child Health, London, UK.

Sci Rep ; 11(1): 24342, 2021 Dec 15.

Article em En | MEDLINE | ID: mdl-34912004

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article